Biomarkers are revolutionising our understanding of melanoma by providing valuable information about a patient's unique tumour characteristics which can help guide clinical decision making.In this podcast, A/Prof Alex Menzies leads a multidisc

Spotlight on mucosal melanoma: Head and neck

Apr 2nd, 2024 41m 12s

Mucosal melanoma is a rare and aggressive form of melanoma that arises from the mucous membrane.In this podcast, we focus on mucosal melanoma of the head and neck. Led by A/Prof Sydney Ch’ng, our multidisciplinary experts discuss how it differ

Dealing with diagnostic uncertainty and borderline pathology

Nov 29th, 2023 41m 28s

Diagnostic uncertainty in the context of cutaneous melanoma can have significant impact on patient care.In this podcast, our multidisciplinary experts, led by Dr Adrian Quek, discuss the challenges faced in classifying melanocytic lesions that

Melanoma: When do I scan?

Sep 27th, 2023 42m 7s

With the advent of effective medical therapies for melanoma, a pertinent question has arisen: When should we scan our patients?In this podcast, our multidisciplinary experts, led by A/Prof Sydney Ch’ng, discuss the balance of whether we should

When to recommend a sentinel node biopsy in melanoma

Jul 7th, 2023 33m 3s

Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas.In this fireside chat from our new SNB Training Program (Sentinel Node Biopsy: From guidelines to practice), MIA’s Prof Georgina Long AO, Prof John Thompson AO

Neoadjuvant immunotherapy: Revolutionising melanoma treatment

Mar 13th, 2023 35m 55s

Our latest podcast explores the innovative approach of neoadjuvant immunotherapy - administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach is creating a buzz among multidisciplinary cl

Unravelling lentigo maligna

Feb 6th, 2023 48m 7s

Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians.In this podcast, Dr Michael Rtshiladze leads a multidisciplinary discussion to unravel our understanding of the pathology, diagnosis

Diagnosis and management of uveal melanoma

Nov 16th, 2022 44m 11s

Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic approaches to metastatic disease are vital.In this podcast, A/Prof Matteo Carlin

Getting the pathology right: Melanoma in General Practice

Aug 31st, 2022 1h 10m

Treating clinicians rely on pathology to help diagnose and stage their patient which fundamentally determines the treatment management plan. Therefore, it is incredibly important to get it right in the first place.In this engaging podcast aim

Critical questions for a melanoma pathologist

Jun 27th, 2022 36m 26s

The role of pathology in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the pathologist for accurate diagnoses and critical pathological information, we decided to reach out to ou

Toxicity management in melanoma

May 17th, 2022 45m 19s

Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of and manage. In this podcast, A/Prof Carlino interviews fellow Medical Oncologist Prof Georgin

The evolving paradigm shift in melanoma

Feb 10th, 2022 45m 44s

The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient outcomes. Through the power of research, day-to-day practice continues to be transformed. In th

Multidisciplinary management of in-transit melanoma

Oct 27th, 2021 28m 4s

Managing in-transit melanoma can be challenging, and it presents and progresses as a heterogeneous disease. Multidisciplinary care is recommended for this complex disease to determine the optimal outcome for the patient. In this engaging podca

Multidisciplinary management of primary melanoma

Jun 29th, 2021 55m 58s

Melanoma has many mimics, making detection a challenge. However, early detection and appropriate management of melanoma is crucial to ensuring a patient has the best chance of survival.

Multidisciplinary management of Merkel cell carcinoma

Apr 28th, 2021 28m 35s

Due to the highly aggressive nature of Merkel cell carcinoma, accurate and timely diagnosis is essential to ensure optimal management. Although our understanding of the biology of the disease has advanced significantly in recent years, a clinic

Multidisciplinary management of SCC and BCC

Mar 30th, 2021 46m 9s

Hear our expert multidisciplinary panel discuss the latest management options for the treatment of squamous cell carcinoma and basal cell carcinoma - the most common forms of non-melanoma skin cancers. They have a wide clinical and pathological

The complexities of adjuvant therapy in melanoma

Feb 10th, 2021 33m 3s

The success of immunotherapy and targeted therapy in the treatment of advanced melanoma has led to the same therapies being used in the adjuvant setting to reduce the risk of recurrence. In this podcast, A/Prof Matteo Carlino interviews fellow

Emerging therapies in advanced melanoma in 2020

Jun 29th, 2020 55m 13s

In the rapidly evolving treatment landscape for advanced melanoma, medical oncologists now have a suite of treatments to choose from for their patients. In this engaging podcast, A/Prof Menzies interviews fellow Medical Oncologist A/Prof Carlin

Melanoma in children and adolescents

Mar 15th, 2020 17m 46s

Melanoma is one of the most common human malignancies, however we often don't often think of it as a disease that occurs in children. Although exceedingly rare, clinicians do need to be aware of paediatric melanoma and have a high level of susp

When should I refer to a melanoma clinic?

Dec 10th, 2019 34m 10s

In the evolving treatment landscape of melanoma, it is important for GPs and Dermatologists to be confident in managing or knowing when to refer their melanoma patients. In this podcast, Surgeon A/Prof Robyn Saw, Dermatologist Dr Annika Smith a

Managing immunotherapy patients in Emergency: Melanoma and beyond

Nov 13th, 2019 41m 31s

Treatment-related oncological emergencies are changing, particularly with a growing number of patients on immunotherapy. It is essential for Emergency Medicine physicians to have an understanding of these drugs and associated toxicities. In th

What GPs need to know about melanoma patients on systemic therapies

Oct 2nd, 2019 26m 6s

In the last decade, the treatment landscape for melanoma has been transformative for patients with advanced disease. Although managed primarily by medical oncologists, it is important for GPs to be across which treatments are available for thei

Food, Mood and Move in Melanoma

May 27th, 2019 1h 8m

Thanks to advancements in therapy, we are now seeing large numbers of patients surviving advanced melanoma, and with that comes well-being and psychological challenges that need to be addressed. Clinicians need to be cognisant of their patients

Management of Brain Metastases in Melanoma

Mar 22nd, 2019 38m 46s

The management of melanoma patients with brain metastases has changed rapidly in the last five years, and patients now have much-improved survival rates. Brain metastases are no longer a death sentence and many people can have control of their

Adjuvant therapy in melanoma

Jan 29th, 2019 27m 58s

Advancements made in medical oncology in the metastatic setting are now being used to benefit melanoma patients with Stage III disease. In this podcast, Medical Oncologist A/Prof Menzies is interviewed by A/Prof Carlino on how adjuvant (postope